Symbols / CGTX Stock $1.28 +1.59% Cognition Therapeutics, Inc.

Healthcare • Biotechnology • United States • NCM
CGTX (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Ms. Lisa Ricciardi
Exch · Country NCM · United States
Market Cap 114.37M
Enterprise Value 78.20M
Income -23.49M
Sales —
FCF (ttm) -31.39M
Book/sh 0.39
Cash/sh 0.41
Employees 14
Insider 10d —
IPO Oct 08, 2021
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -4.27
PEG —
P/S —
P/B 3.32
P/C —
EV/EBITDA -1.64
EV/Sales —
Quick Ratio 3.36
Current Ratio 3.45
Debt/Eq 1.86
LT Debt/Eq —
EPS (ttm) -0.32
EPS next Y -0.30
EPS Growth —
Revenue Growth —
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-03-26
Earnings (prior) 2026-03-26
ROA -75.99%
ROE -88.59%
ROIC —
Gross Margin 0.00%
Oper. Margin 0.00%
Profit Margin 0.00%
Shs Outstand 89.35M
Shs Float 82.53M
Insider Own 2.26%
Instit Own 23.60%
Short Float 8.81%
Short Ratio 4.84
Short Interest 7.32M
52W High 3.83
vs 52W High -66.58%
52W Low 0.22
vs 52W Low 476.58%
Beta 1.40
Impl. Vol. —
Rel Volume 0.62
Avg Volume 1.12M
Volume 694.16K
Target (mean) $3.50
Tgt Median $3.50
Tgt Low $3.00
Tgt High $4.00
# Analysts 4
Recom None
Prev Close $1.26
Price $1.28
Change 1.59%
About

Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is zervimesine, an orally delivered small molecule to protect neuronal synapses by preventing the binding of oligomers of pathogenic proteins, which is in Phase 2 clinical studies for the treatment of Alzheimer's disease and Mild Cognitive Impairment, as well as geographic atrophy secondary to dry age-related macular degeneration and dementia with Lewy bodies. Cognition Therapeutics, Inc. was incorporated in 2007 and is based in Purchase, New York.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$3.50
Mean price target
2. Current target
$1.28
Latest analyst target
3. DCF / Fair value
$-6.32
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$1.28
Low
$3.00
High
$4.00
Mean
$3.50

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-03-27 main Chardan Capital Buy → Buy $4
2025-12-04 reit HC Wainwright & Co. Buy → Buy $3
2025-11-21 reit B. Riley Securities Buy → Buy $3
2025-11-19 reit HC Wainwright & Co. Buy → Buy $3
2025-08-08 main Chardan Capital Buy → Buy $4
2025-06-26 reit HC Wainwright & Co. Buy → Buy $3
2025-05-27 main HC Wainwright & Co. Buy → Buy $3
2025-05-08 main Chardan Capital Buy → Buy $4
2025-03-24 main HC Wainwright & Co. Buy → Buy $5
2025-03-21 main Chardan Capital Buy → Buy $8
2025-02-26 main Chardan Capital Buy → Buy $11
2024-12-19 up B. Riley Securities Neutral → Buy $2
2024-12-19 main Chardan Capital Buy → Buy $11
2024-12-19 main HC Wainwright & Co. Buy → Buy $6
2024-11-27 reit HC Wainwright & Co. Buy → Buy $5
2024-11-15 main Chardan Capital Buy → Buy $11
2024-11-04 reit HC Wainwright & Co. Buy → Buy $5
2024-10-31 main Chardan Capital Buy → Buy $11
2024-08-12 main HC Wainwright & Co. Buy → Buy $5
2024-08-06 down B. Riley Securities Buy → Neutral $1
News
RSS: Latest CGTX news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-16 RICCIARDI LISA Chief Executive Officer — 9,175 $1.10 $10,092
2026-04-16 DOYLE JOHN BRENDAN Chief Financial Officer — 10,000 $1.13 $11,300
2026-04-16 CAGGIANO ANTHONY Officer — 10,000 $1.11 $11,100
2026-02-03 RICCIARDI LISA Chief Executive Officer — 800,000 $0.00 $0
2026-02-03 DOYLE JOHN BRENDAN Chief Financial Officer — 200,000 $0.00 $0
2026-02-03 CAGGIANO ANTHONY Officer — 400,000 $0.00 $0
2025-12-18 RICCIARDI LISA Chief Executive Officer — 75,000 $0.00 $0
2025-12-18 DOYLE JOHN BRENDAN Chief Financial Officer — 30,000 $0.00 $0
2025-12-18 CAGGIANO ANTHONY Officer — 65,000 $0.00 $0
2025-09-19 FLETCHER AARON G.L. Director and Beneficial Owner of more than 10% of a Class of Security — 7,729 $0.84 $6,492
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
0.00
0.00
0.00
0.00
Operating Revenue
0.00
0.00
0.00
0.00
Operating Expense
24.39
-29.13%
34.42
+32.79%
25.92
+21.49%
21.33
Research And Development
37.19
-10.77%
41.68
+12.04%
37.20
+22.66%
30.32
Selling General And Administration
10.61
-13.65%
12.29
-9.15%
13.53
+2.28%
13.23
General And Administrative Expense
10.61
-13.65%
12.29
-9.15%
13.53
+2.28%
13.23
Other Gand A
10.61
-13.65%
12.29
-9.15%
13.53
+2.28%
13.23
Other Operating Expenses
-23.41
-19.73%
-19.55
+21.19%
-24.80
-11.65%
-22.22
Total Expenses
24.39
-29.13%
34.42
+32.79%
25.92
+21.49%
21.33
Operating Income
-24.39
+29.13%
-34.42
-32.79%
-25.92
-21.49%
-21.33
Total Operating Income As Reported
-47.80
+11.43%
-53.97
-6.39%
-50.72
-16.47%
-43.55
EBITDA
-23.25
+30.98%
-33.68
-32.03%
-25.51
-20.70%
-21.13
Normalized EBITDA
-23.25
+30.58%
-33.48
-31.27%
-25.51
-20.70%
-21.13
Reconciled Depreciation
0.23
-14.29%
0.27
+5.56%
0.25
+7.23%
0.23
EBIT
-23.47
+30.85%
-33.95
-31.77%
-25.76
-20.55%
-21.37
Total Unusual Items
0.00
+100.00%
-0.20
0.00
0.00
Total Unusual Items Excluding Goodwill
0.00
+100.00%
-0.20
0.00
0.00
Special Income Charges
0.00
+100.00%
-0.20
0.00
0.00
Other Special Charges
—
—
—
—
Net Income
-23.49
+30.86%
-33.97
-31.73%
-25.79
-20.52%
-21.40
Pretax Income
-23.49
+30.86%
-33.97
-31.73%
-25.79
-20.52%
-21.40
Net Non Operating Interest Income Expense
-0.01
+48.00%
-0.03
+7.41%
-0.03
+3.57%
-0.03
Interest Expense Non Operating
0.01
-48.00%
0.03
-7.41%
0.03
-3.57%
0.03
Net Interest Income
-0.01
+48.00%
-0.03
+7.41%
-0.03
+3.57%
-0.03
Interest Expense
0.01
-48.00%
0.03
-7.41%
0.03
-3.57%
0.03
Other Income Expense
0.92
+95.12%
0.47
+198.10%
0.16
+551.43%
-0.04
Other Non Operating Income Expenses
0.92
+37.99%
0.67
+321.52%
0.16
+551.43%
-0.04
Gain On Sale Of Security
—
—
—
—
Gain On Sale Of Business
0.00
+100.00%
-0.20
0.00
—
Tax Rate For Calcs
0.00
0.00
0.00
0.00
Tax Effect Of Unusual Items
0.00
0.00
0.00
0.00
Net Income Including Noncontrolling Interests
-23.49
+30.86%
-33.97
-31.73%
-25.79
-20.52%
-21.40
Net Income From Continuing Operation Net Minority Interest
-23.49
+30.86%
-33.97
-31.73%
-25.79
-20.52%
-21.40
Net Income From Continuing And Discontinued Operation
-23.49
+30.86%
-33.97
-31.73%
-25.79
-20.52%
-21.40
Net Income Continuous Operations
-23.49
+30.86%
-33.97
-31.73%
-25.79
-20.52%
-21.40
Normalized Income
-23.49
+30.46%
-33.78
-30.98%
-25.79
-20.52%
-21.40
Net Income Common Stockholders
-23.49
+30.86%
-33.97
-31.73%
-25.79
-20.52%
-21.40
Diluted EPS
-0.32
+62.79%
-0.86
+0.00%
-0.86
+5.49%
-0.91
Basic EPS
-0.32
+62.79%
-0.86
+0.00%
-0.86
+5.49%
-0.91
Basic Average Shares
72.77
+83.15%
39.73
+32.31%
30.03
+27.03%
23.64
Diluted Average Shares
72.77
+83.15%
39.73
+32.31%
30.03
+27.03%
23.64
Diluted NI Availto Com Stockholders
-23.49
+30.86%
-33.97
-31.73%
-25.79
-20.52%
-21.40
Preferred Stock Dividends
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
48.39
+60.05%
30.23
-14.02%
35.16
-30.27%
50.42
Current Assets
47.99
+62.38%
29.55
-13.64%
34.22
-28.18%
47.65
Cash Cash Equivalents And Short Term Investments
36.81
+47.19%
25.01
-16.42%
29.92
-28.01%
41.56
Cash And Cash Equivalents
36.81
+47.19%
25.01
-16.42%
29.92
-28.01%
41.56
Receivables
9.92
+269.43%
2.69
+109.68%
1.28
-65.11%
3.67
Other Receivables
9.92
+269.43%
2.69
+109.68%
1.28
-65.11%
3.67
Prepaid Assets
—
—
—
—
Restricted Cash
0.19
0.00
—
—
Other Current Assets
1.07
-42.58%
1.86
-38.39%
3.02
+25.11%
2.41
Total Non Current Assets
0.40
-41.24%
0.68
-27.84%
0.94
-66.13%
2.78
Net PPE
0.40
-41.24%
0.68
-27.84%
0.94
-10.04%
1.05
Gross PPE
0.59
-68.07%
1.83
-7.79%
1.99
-0.45%
2.00
Accumulated Depreciation
-0.19
+83.82%
-1.16
-10.20%
-1.05
-10.07%
-0.95
Properties
0.00
0.00
0.00
0.00
Buildings And Improvements
0.31
-38.55%
0.50
-24.20%
0.66
-19.19%
0.81
Machinery Furniture Equipment
0.14
-1.43%
0.14
+0.00%
0.14
+8.53%
0.13
Other Properties
0.14
-88.14%
1.20
+0.34%
1.19
+12.87%
1.06
Other Non Current Assets
—
—
—
1.73
Total Liabilities Net Minority Interest
14.12
+22.94%
11.48
+7.44%
10.69
+5.04%
10.18
Current Liabilities
13.92
+24.97%
11.14
+9.57%
10.17
+30.46%
7.79
Payables And Accrued Expenses
11.54
+42.92%
8.08
+22.67%
6.58
+48.31%
4.44
Payables
1.12
-43.60%
1.98
-46.31%
3.69
+14.89%
3.22
Accounts Payable
1.12
-43.60%
1.98
-46.31%
3.69
+14.89%
3.22
Current Accrued Expenses
10.43
+71.09%
6.09
+110.87%
2.89
+136.11%
1.22
Pensionand Other Post Retirement Benefit Plans Current
1.57
+2.82%
1.53
+30.99%
1.17
+33.91%
0.87
Current Debt And Capital Lease Obligation
0.44
-6.14%
0.47
-34.26%
0.72
-8.30%
0.78
Current Debt
0.31
+10.04%
0.28
-48.71%
0.54
-14.20%
0.63
Other Current Borrowings
0.31
+10.04%
0.28
-48.71%
0.54
-14.20%
0.63
Current Capital Lease Obligation
0.14
-29.53%
0.19
+10.92%
0.17
+16.78%
0.15
Current Deferred Liabilities
0.37
-65.57%
1.07
-37.33%
1.70
-0.06%
1.70
Current Deferred Revenue
0.37
-65.57%
1.07
-37.33%
1.70
-0.06%
1.70
Other Current Liabilities
—
—
—
—
Total Non Current Liabilities Net Minority Interest
0.20
-42.98%
0.34
-34.23%
0.52
-78.16%
2.38
Long Term Debt And Capital Lease Obligation
0.20
-42.98%
0.34
-34.23%
0.52
-25.18%
0.69
Long Term Capital Lease Obligation
0.20
-42.98%
0.34
-34.23%
0.52
-25.18%
0.69
Non Current Deferred Liabilities
—
—
0.00
-100.00%
1.69
Non Current Deferred Revenue
—
—
0.00
-100.00%
1.69
Preferred Securities Outside Stock Equity
—
—
—
—
Stockholders Equity
34.27
+82.78%
18.75
-23.39%
24.47
-39.19%
40.25
Common Stock Equity
34.27
+82.78%
18.75
-23.39%
24.47
-39.19%
40.25
Capital Stock
0.09
+50.00%
0.06
+87.50%
0.03
+10.34%
0.03
Common Stock
0.09
+50.00%
0.06
+87.50%
0.03
+10.34%
0.03
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
88.90
+48.53%
59.85
+86.08%
32.17
+10.95%
28.99
Ordinary Shares Number
88.90
+48.53%
59.85
+86.08%
32.17
+10.95%
28.99
Additional Paid In Capital
232.83
+20.11%
193.85
+16.90%
165.83
+6.42%
155.82
Retained Earnings
-198.65
-13.41%
-175.16
-24.06%
-141.19
-22.35%
-115.40
Gains Losses Not Affecting Retained Earnings
—
0.00
+100.00%
-0.20
+2.01%
-0.20
Other Equity Adjustments
—
—
-0.20
+2.01%
-0.20
Total Equity Gross Minority Interest
34.27
+82.78%
18.75
-23.39%
24.47
-39.19%
40.25
Total Capitalization
34.27
+82.78%
18.75
-23.39%
24.47
-39.19%
40.25
Working Capital
34.07
+85.02%
18.41
-23.45%
24.05
-39.64%
39.85
Invested Capital
34.58
+81.71%
19.03
-23.94%
25.02
-38.81%
40.88
Total Debt
0.64
-21.62%
0.81
-34.25%
1.24
-16.24%
1.48
Capital Lease Obligations
0.33
-38.13%
0.54
-22.91%
0.69
-17.77%
0.84
Net Tangible Assets
34.27
+82.78%
18.75
-23.39%
24.47
-39.19%
40.25
Tangible Book Value
34.27
+82.78%
18.75
-23.39%
24.47
-39.19%
40.25
Derivative Product Liabilities
—
—
—
—
Non Current Accrued Expenses
—
—
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-24.59
+13.65%
-28.47
-77.76%
-16.02
+13.57%
-18.53
Cash Flow From Continuing Operating Activities
-24.59
+13.65%
-28.47
-77.76%
-16.02
+13.57%
-18.53
Net Income From Continuing Operations
-23.49
+30.86%
-33.97
-31.73%
-25.79
-20.52%
-21.40
Depreciation Amortization Depletion
0.23
-14.29%
0.27
+5.56%
0.25
+7.23%
0.23
Depreciation
0.23
-14.29%
0.27
+5.56%
0.25
+7.23%
0.23
Depreciation And Amortization
0.23
-14.29%
0.27
+5.56%
0.25
+7.23%
0.23
Other Non Cash Items
—
—
0.32
—
Stock Based Compensation
2.09
-44.32%
3.75
-13.92%
4.35
+21.89%
3.57
Operating Gains Losses
0.04
-78.97%
0.20
—
—
Gain Loss On Investment Securities
—
—
—
—
Net Foreign Currency Exchange Gain Loss
0.00
-100.00%
0.20
0.00
—
Gain Loss On Sale Of PPE
0.04
0.00
—
—
Change In Working Capital
-3.46
-368.40%
1.29
-73.42%
4.85
+613.89%
-0.94
Change In Receivables
-7.24
-415.09%
-1.41
-158.76%
2.39
+270.06%
-1.41
Change In Prepaid Assets
1.17
-28.17%
1.63
-11.83%
1.85
+242.24%
-1.30
Change In Payables And Accrued Expense
3.51
+89.32%
1.85
-24.02%
2.44
+425.77%
-0.75
Change In Accrued Expense
—
—
—
0.34
Change In Payable
—
—
—
-1.09
Change In Account Payable
—
—
—
-1.09
Change In Other Working Capital
-0.70
-10.08%
-0.64
+62.36%
-1.69
-164.02%
2.63
Change In Other Current Assets
—
—
—
-1.73
Change In Other Current Liabilities
-0.20
-28.30%
-0.16
-6.00%
-0.15
-23.97%
-0.12
Investing Cash Flow
0.01
+325.00%
-0.00
+97.28%
-0.15
+14.04%
-0.17
Cash Flow From Continuing Investing Activities
0.01
+325.00%
-0.00
+97.28%
-0.15
+14.04%
-0.17
Net PPE Purchase And Sale
0.01
+325.00%
-0.00
+97.28%
-0.15
+14.04%
-0.17
Purchase Of PPE
0.00
+100.00%
-0.00
+97.28%
-0.15
+14.04%
-0.17
Sale Of PPE
0.01
0.00
—
—
Capital Expenditure
—
-0.00
+97.28%
-0.15
+14.04%
-0.17
Financing Cash Flow
36.57
+55.19%
23.57
+421.23%
4.52
-18.48%
5.55
Cash Flow From Continuing Financing Activities
36.57
+55.19%
23.57
+421.23%
4.52
-18.48%
5.55
Net Issuance Payments Of Debt
-0.35
+52.23%
-0.74
+8.88%
-0.81
+41.91%
-1.40
Issuance Of Debt
—
—
—
—
Repayment Of Debt
-0.35
+52.23%
-0.74
+8.88%
-0.81
+41.91%
-1.40
Long Term Debt Issuance
—
—
—
—
Long Term Debt Payments
-0.35
+52.23%
-0.74
+8.88%
-0.81
+41.91%
-1.40
Net Long Term Debt Issuance
-0.35
+52.23%
-0.74
+8.88%
-0.81
+41.91%
-1.40
Net Common Stock Issuance
37.02
+52.02%
24.35
+356.68%
5.33
+0.15%
5.32
Proceeds From Stock Option Exercised
0.07
-13.41%
0.08
0.00
-100.00%
1.62
Net Other Financing Charges
-0.16
-28.13%
-0.13
—
—
Changes In Cash
11.99
+344.07%
-4.91
+57.81%
-11.64
+11.51%
-13.16
Effect Of Exchange Rate Changes
—
0.00
-100.00%
0.00
+500.00%
-0.00
Beginning Cash Position
25.01
-16.42%
29.92
-28.01%
41.56
-24.05%
54.72
End Cash Position
37.00
+47.95%
25.01
-16.42%
29.92
-28.01%
41.56
Free Cash Flow
-24.59
+13.66%
-28.48
-76.17%
-16.16
+13.57%
-18.70
Common Stock Issuance
37.02
+52.02%
24.35
+356.68%
5.33
+0.15%
5.32
Issuance Of Capital Stock
37.02
+52.02%
24.35
+356.68%
5.33
+0.15%
5.32
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category